Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anna Miserocchi
Observed names:
A. Miserocchi,
Miserocchi, Anna
Institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Observed institution:
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
ORCID:
0000-0003-1087-9146
Observed ORCID:
0000-0003-1087-9146
OpenAlex ID:
A5137097071
Post-VABB Cavity-Targeted Avidin-Pretargeted [90Y]Y-DOTA-Biotin in Nonpalpable Breast Cancer: A Phase I Activity-Escalation Study (ARTHE)
2026
·
Maddalena Sansovini
, Paola Sanna
, et al.
·
Cancers
Combining immune checkpoint inhibition and dendritic cell vaccination in advanced pleural and peritoneal mesothelioma: The phase 1b MESOVAX trial.
2026
·
Laura Ridolfi
, Angelo Delmonte
, et al.
·
Journal of Clinical Oncology
122eTiP CombiCoR-Vax trial: Study protocol for a phase II, single-arm, multicenter trial of sequential pembrolizumab plus dendritic cell vaccine followed by trifluridine/tipiracil and bevacizumab in refractory microsatellite-stable metastatic colorectal cancer
2025
·
F.G. Sullo
, A. Passardi
, et al.
·
Immuno-Oncology Technology
Show more works
View as search
Works count:
5
Citation count:
H-index:
I10-index:
Year
Topic
Type